Screener / SEC EDGAR /CIK 0001802768 /10-K filed Feb 11, 2026, compared with Feb 12, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Pharmaceuticals

Royalty Pharma plc RPRX

Compare with peers Embed
Accounting checks on the latest 10-K

1 fact worth reading about, 8 checks with nothing to note

10-K, 8-K and filing index
Worth reading about 1 facts that a reader may want to look into
Nothing to note 8 checks where the filing shows nothing unusual
Not applicable 2 checks that do not fit this company

Facts from the latest 10-K that are worth reading about. They are not a verdict on the company.

What each check found

Each one cites its filing

  • Critical audit matters changed
    New this year: Initial recognition and valuation of Employee EPAs assumed as part of the Internalization (“As described in Note 3 to the consolidated financial statements, on May 16, 2025, the Company completed its acquisition of Royalty Pharma Manager, LLC for total consideration of $565.2 million (the “Internalization”). The transaction was accounted for as a business combination. As a result of the In”). Same as last year: Valuation of Financial Royalty Assets and related Interest Income
  • Cash from operations lower than net income
    Cash from operations $2.5B vs net income $770.9M (FY ending Dec 31, 2025)
  • Auditor change
    Same auditor in both 10-Ks: Ernst & Young LLP
    Source: 10-K 0001802768-26-000003: auditor Ernst & Young LLP; 10-K 0001802768-25-000010: auditor Ernst & Young LLP; no 8-K item 4.01 in the last 2 years
  • Going concern language
    No statement of substantial doubt about going concern
  • Restatement (8-K item 4.02)
    No 8-K item 4.02 in the last 2 years
    Source: Filing index, 8-Ks since Nov 15, 2024
  • Late filing notice (NT 10-K or NT 10-Q)
    No NT 10-K or NT 10-Q in the last 2 years
    Source: Filing index since Nov 15, 2024
  • Material weakness in internal control
    No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • Material impairment (8-K item 2.06)
    No 8-K item 2.06 in the last 2 years
    Source: Filing index, 8-Ks since Nov 15, 2024
  • Bankruptcy (8-K item 1.03)
    No 8-K item 1.03 in the last 2 years
    Source: Filing index, 8-Ks since Nov 15, 2024
  • Receivables growing faster than revenue not applicable
    The 10-K does not report receivables for both years.
  • Inventory growing faster than revenue not applicable
    The 10-K does not report inventory for both years.

Did the profit turn into cash?

Net income against operating cash flow, FY2018 to FY2025 · 10-K XBRL

Over 8 years, every $1 of net income came with $2.18 of operating cash flow. In 1 of the 8 years cash came in below profit.

FY2018 net income 1.4B · NetIncomeLoss, 0001802768-21-000006FY2018 operating cash flow 1.6B · NetCashProvidedByUsedInOperatingActivities, 0001802768-21-000006 1.17× FY2018 FY2019 net income 2.3B · NetIncomeLoss, 0001802768-22-000011FY2019 operating cash flow 1.7B · NetCashProvidedByUsedInOperatingActivities, 0001802768-22-000011 0.71× FY2019 FY2020 net income 975.0M · NetIncomeLoss, 0001802768-23-000007FY2020 operating cash flow 2.0B · NetCashProvidedByUsedInOperatingActivities, 0001802768-23-000007 2.09× FY2020 FY2021 net income 619.7M · NetIncomeLoss, 0001802768-24-000012FY2021 operating cash flow 2.0B · NetCashProvidedByUsedInOperatingActivities, 0001802768-24-000012 3.26× FY2021 FY2022 net income 42.8M · NetIncomeLoss, 0001802768-25-000010FY2022 operating cash flow 2.1B · NetCashProvidedByUsedInOperatingActivities, 0001802768-25-000010 50.06× FY2022 FY2023 net income 1.1B · NetIncomeLoss, 0001802768-26-000003FY2023 operating cash flow 3.0B · NetCashProvidedByUsedInOperatingActivities, 0001802768-26-000003 2.63× FY2023 FY2024 net income 859.0M · NetIncomeLoss, 0001802768-26-000003FY2024 operating cash flow 2.8B · NetCashProvidedByUsedInOperatingActivities, 0001802768-26-000003 3.22× FY2024 FY2025 net income 770.9M · NetIncomeLoss, 0001802768-26-000003FY2025 operating cash flow 2.5B · NetCashProvidedByUsedInOperatingActivities, 0001802768-26-000003 3.23× FY2025
Net income Operating cash flow The figure above each year is cash flow ÷ net income; amber when below 1. Hover a bar for its XBRL tag and filing.

Published score, FY2025

Published formulas · 10-K line items

Academic formulas, worked out from this company's 10-K numbers. They describe a pattern in the figures; they do not say what the company did, and they are not a view on the shares. Every input is a line item from the filing.

One point for each test the company passes. The paper used it on low price-to-book companies; here it is shown as a summary of the year's financial direction.

The tests
Return on assets is positiveNet income / assets at the start of the year, above zero.✓ 1
Cash from operations is positiveOperating cash flow above zero.✓ 1
Return on assets roseThis year's return on assets above last year's.– 0
Cash from operations exceeds net incomeOperating cash flow / assets above return on assets.✓ 1
Long-term debt fell relative to assetsLong-term debt / average assets lower than last year.– 0
Current ratio roseCurrent assets / current liabilities above last year's.✓ 1
No new shares issuedDiluted share count not above last year's (the paper tests for an equity offering).✓ 1
Gross margin rose(Revenue - cost of revenue) / revenue above last year's.n/a
Asset turnover roseRevenue / assets at the start of the year above last year's.– 0

What it does not mean: a low score is not a prediction of a fall, and a high score is not a reason to buy. A test the XBRL could not support is shown as n/a and left out of the total.

How each check works

what it measures, the threshold, what it does not mean
CheckWhat it measuresWhen it is markedWhat it does not mean
Receivables growing faster than revenueWhether customers owe more, relative to sales, than a year ago.Receivables grew more than 10 percentage points faster than revenue, and grew.Not proof that revenue is overstated. A large deal at year end, longer payment terms or an acquisition can do the same.
Cash from operations lower than net incomeWhether reported profit is backed by cash from the business.Cash from operations is below net income. Not computed for banks and other financial companies.Common in fast-growing or seasonal companies. It is a question to ask, not a failure.
Inventory growing faster than revenueWhether stock is piling up relative to sales.Inventory grew more than 10 percentage points faster than revenue, and grew.May be a planned build ahead of a product launch or a supply-chain change.
Auditor changeWhether the company changed its auditor.An 8-K item 4.01 in the last 2 years, or a different auditor name in the two latest 10-Ks.Often routine: rotation, a tender, or an audit firm merger.
Going concern languageWhether the 10-K states substantial doubt about continuing as a going concern.A sentence to that effect is found in the 10-K text. Quoted as filed.The wording is the company's, not our estimate. It can also appear in a sentence saying the doubt was removed.
Restatement (8-K item 4.02)Whether the company said earlier financial statements should no longer be relied on.An 8-K item 4.02 in the last 2 years.Some restatements are small and do not change the picture.
Late filing noticeWhether the company asked for more time to file a 10-K or 10-Q.An NT 10-K or NT 10-Q in the last 2 years.Delays can be technical and one-off.
Critical audit matters changedWhich topics the auditor singled out as most difficult, and whether they changed.A matter is new in the latest 10-K compared with the one before.A new matter shows where the auditor spent its effort, not that something is wrong.
Material weakness in internal controlWhether the 10-K concludes that internal control over financial reporting was not effective because of a material weakness.A sentence in the 10-K text concludes that controls were not effective because of a material weakness, quoted as filed. Sentences that say there is none, that one could occur, or that an earlier one was fixed are not marked.It is the company's or the auditor's own wording, not our estimate. Many are about one account or process and are fixed within a year. It does not say the numbers are wrong.
Material impairment (8-K item 2.06)Whether the company told the SEC it expects a material charge for impaired assets, such as goodwill.An 8-K item 2.06 in the last 2 years.A non-cash write-down. It says an earlier value was too high, not that the business is failing or that cash ran out.
Bankruptcy (8-K item 1.03)Whether the company filed for bankruptcy or receivership.An 8-K item 1.03 in the last 2 years.The filing is the company's own and is a fact. It does not say what shareholders will get or whether the business continues.

The 10-point threshold is our choice, not an academic result. Every check cites the filing and the line items it used.

The auditor

Auditor's report in the 10-K filed Feb 11, 2026

Firm Ernst & Young LLP Boston, Massachusetts
Auditor since 2022 4 years
Critical audit matters 2 1 the year before

What the auditor found hardest this year

  • Initial recognition and valuation of Employee EPAs assumed as part of the InternalizationNew this yearAs described in Note 3 to the consolidated financial statements, on May 16, 2025, the Company completed its acquisition of Royalty Pharma Manager, LLC for total consideration of $565.2 million (the “Internalization”). The transaction was accounted for as a business combination. As a result of the Internalization...
  • Valuation of Financial Royalty Assets and related Interest IncomeAlso last yearAs disclosed in Note 8 to the consolidated financial statements, the Company’s total financial royalty assets, net, were carried at $17,062,868 thousand as of December 31, 2025. For the year ended December 31, 2025, the Company recognized income from financial royalty assets of $2,261,152 thousand. As explained in...

The first year is from the report's own sentence "We have served as the Company's auditor since ...". Critical audit matters are the parts of the audit the auditor judged hardest; a new one is worth reading. A long tenure is common and not a finding by itself. Open the 10-K

Sources

The latest 10-K and its XBRL, the auditor's report, and 8-K items 4.01, 4.02, 2.06 and 1.03 in the filing index. Each check names its source.

Also

Revised numbers: past numbers a later 10-K reports differently.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/RPRX/export.csv") into a cell.

Next:Revised numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.